CA
AUPH icon

Cliff Asness’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cliff Asness’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Sell
948,751
-59
-0% -$943 0.01% 1283
2026
Q1 		$14.1M Buy
948,810
+467,474
+97% +$6.83M 0.01% 1185
2025
Q4 		$7.68M Buy
481,336
+123,044
+34% +$1.74M ﹤0.01% 1335
2025
Q3 		$3.96M Buy
358,292
+143,642
+67% +$1.57M ﹤0.01% 1588
2025
Q2 		$1.82M Sell
214,650
-288,893
-57% -$2.32M ﹤0.01% 1837
2025
Q1 		$4.05M Buy
503,543
+40,380
+9% +$327K ﹤0.01% 1234
2024
Q4 		$4.16M Sell
463,163
-105,155
-19% -$858K 0.01% 1179
2024
Q3 		$4.17M Buy
568,318
+366,077
+181% +$2.27M 0.01% 1142
2024
Q2 		$1.15M Buy
+202,241
New +$1.07M ﹤0.01% 1686
2024
Q1 		– Sell
-21,435
Closed -$193K – 2415
2023
Q4 		$193K Buy
21,435
+2,829
+15% +$23.3K ﹤0.01% 2223
2023
Q3 		$145K Buy
18,606
+7,446
+67% +$72.8K ﹤0.01% 2185
2023
Q2 		$108K Sell
11,160
-12,454
-53% -$129K ﹤0.01% 2141
2023
Q1 		$259K Buy
23,614
+11,658
+98% +$103K ﹤0.01% 1984
2022
Q4 		$51.6K Buy
+11,956
New +$69.4K ﹤0.01% 2169

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cliff Asness's AUPH Position: Q2 2026 in Review

Cliff Asness reduced its Aurinia Pharmaceuticals (AUPH) stake by 0.01% in Q2 2026, selling an estimated $943 and leaving 948,751 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #1283.

Cliff Asness first reported a position in AUPH in Q4 2022 and has held it in 14 quarters since. 279 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Cliff Asness held 948,751 shares of Aurinia Pharmaceuticals worth $16.1M as of Q2 2026.
  • Cliff Asness sold 59 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $943.
  • Aurinia Pharmaceuticals made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1283 holding.
  • Cliff Asness first reported a position in Aurinia Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • 279 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.